BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27496530)

  • 1. Effectiveness of ovarian age as the background risk for aneuploidy screening in an unselected pregnant population.
    Grande M; Sabrià J; Borobio V; Mercadé I; Stergiotou I; Masoller N; Borrell A
    Reprod Biomed Online; 2016 Oct; 33(4):500-505. PubMed ID: 27496530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages.
    Grande M; Borobio V; Bennasar M; Stergiotou I; Mercadé I; Masoller N; Peñarrubia J; Borrell A
    Fertil Steril; 2015 May; 103(5):1221-7.e2. PubMed ID: 25796318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antral follicle count as a marker of ovarian biological age to reflect the background risk of fetal aneuploidy.
    Grande M; Borobio V; Jimenez JM; Bennasar M; Stergiotou I; Peñarrubia J; Borrell A
    Hum Reprod; 2014 Jun; 29(6):1337-43. PubMed ID: 24682614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging.
    Bentzen JG; Forman JL; Johannsen TH; Pinborg A; Larsen EC; Andersen AN
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1602-11. PubMed ID: 23463653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Müllerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history.
    Nardo LG; Christodoulou D; Gould D; Roberts SA; Fitzgerald CT; Laing I
    Gynecol Endocrinol; 2007; 23(8):486-93. PubMed ID: 17852428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
    Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
    Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone.
    Fleming R; Seifer DB; Frattarelli JL; Ruman J
    Reprod Biomed Online; 2015 Oct; 31(4):486-96. PubMed ID: 26283017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of age-related changes in anti-Müllerian hormone levels and other ovarian reserve tests between healthy fertile and infertile population.
    Bozkurt B; Erdem M; Mutlu MF; Erdem A; Guler I; Mutlu I; Oktem M
    Hum Fertil (Camb); 2016 Sep; 19(3):192-8. PubMed ID: 27499425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
    Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
    Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
    Nelson SM; Klein BM; Arce JC
    Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of antral follicle count and anti-Müllerian hormone for follicle and oocyte developmental competence during the early prepubertal period in a sheep model.
    Torres-Rovira L; Gonzalez-Bulnes A; Succu S; Spezzigu A; Manca ME; Leoni GG; Sanna M; Pirino S; Gallus M; Naitana S; Berlinguer F
    Reprod Fertil Dev; 2014 Oct; 26(8):1094-106. PubMed ID: 24008140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
    Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
    Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related nomograms for antral follicle count and anti-Mullerian hormone for subfertile Chinese women in Singapore.
    Loy SL; Cheung YB; Fortier MV; Ong CL; Tan HH; Nadarajah S; Chan JKY; Viardot-Foucault V
    PLoS One; 2017; 12(12):e0189830. PubMed ID: 29240820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left-right differences in ovarian volume and antral follicle count in 1423 women of reproductive age.
    Korsholm AS; Hvidman HW; Bentzen JG; Nyboe Andersen A; Birch Petersen K
    Gynecol Endocrinol; 2017 Apr; 33(4):320-323. PubMed ID: 27910705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low anti-Müllerian hormone concentration is associated with increased risk of embryonic aneuploidy in women of advanced age.
    Jiang X; Yan J; Sheng Y; Sun M; Cui L; Chen ZJ
    Reprod Biomed Online; 2018 Aug; 37(2):178-183. PubMed ID: 29724534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimullerian hormone in cases of different reproductive pathologies.
    Barbakadze L; Kristasashvili J
    Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.